Sfoglia per Autore
Abdominal aortic aneurysm in renal transplant recipients
2005 E. Favi, F. Citterio, V. Tondolo, A. Chirico, A. Brescia, J. Romagnoli, M. Castagneto
Gonadal function and immunosuppressive therapy after renal transplantation
2005 V. Tondolo, F. Citterio, N. Panocchia, G. Nanni, E. Favi, A. Brescia, M. Castagneto
Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine
2006 J. Romagnoli, F. Citterio, G. Nanni, E. Favi, V. Tondolo, G. Spagnoletti, M.P. Salerno, M. Castagneto
A prospective trial comparing tacrolimus with everolimus and low dose cyclosporine
2007 E. Favi, F. Citterio, G. Spagnoletti, V. Tondolo, J. Romagnoli, M. Castagneto
Low everolimus exposure is associated with higher incidence of acute rejection in renal allograft recipients
2007 J. Romagnoli, F. Citterio, E. Favi, G. Spagnoletti, V. Tondolo, M.P. Salemo, N. Castaneto
Higher Incidence of Acute Rejection in Renal Transplant Recipients With Low Everolimus Exposure
2007 J. Romagnoli, F. Citterio, E. Favi, M.P. Salerno, V. Tondolo, G. Spagnoletti, R. Renna, M. Castagneto
Post transplant diabetes mellitus in kidney transplant recipients: A potential diabetogenic role for sirolimus?
2007 J. Romagnoli, F. Citterio, E. Favi, G. Spagnoletti, M.P. Salerno, M. Castagneto
Cardiovascular risk profile in kidney transplant recipients treated with two immunosuppressive regimens: Tacrolimus-MMF-Prednisone vs Everolimus-low dose Cyclosporine-Prednisone
2008 E. Favi, F. Citterio, G. Spagnoletti, I. De Santis, F. Delreno, J. Romagnoli, A. Gargiulo, A. Maida, M. Castagneto
Tacrolimus-MMF-Prednisone vs everolimus-low dose cyclosporine-prednisone: 1 year results of a prospective clinical trial
2008 E. Favi, F. Citterio, G. Spagnoletti, F. Delreno, I. De Santis, C. Bertolaso, J. Romagnoli, A. Gargiulo, M. Castagneto
How to predict the cardiovascular (CV) risk after renal transplantation
2009 M.P. Salerno, E. Zichichi, E. Rossi, F. Citterio, E. Favi, G. Spagnoletti, M. Castagneto
Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up
2009 E. Favi, F. Citterio, G. Spagnoletti, A. Gargiulo, F. Delreno, J. Romagnoli, M. Castagneto
Long-Term Clinical Impact of Vesicoureteral Reflux in Kidney Transplantation
2009 E. Favi, G. Spagnoletti, A.L. Valentini, V. Tondolo, G. Nanni, F. Citterio, M. Castagneto
A prospective clinical trial comaring tacrolimus-MMF to cyclosporine-everolimus in de novo renal transplant recipients: 2 years results
2009 E. Favi, F. Citterio, G. Spagnoletti, A. Gargiulo, J. Romagnoli, M. Castagneto
Prevention of cardiovascular complication after renal transplantation
2009 E. Rossi, M.P. Salerno, E. Zichici, E. Favi, G. Spagnoletti, F. Citterio
A prospective clinical trial comparing tacrolimus-MMF to cyclosporine-everolimus in de novo renal transplant recipients: 2 years results
2009 E. Favi, F. Citterio, G. Spagnoletti, A. Gargiulo, J. Romagnoli, M. Castagneto
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine
2009 G. Spagnoletti, F. Citterio, E. Favi, E. Rossi, F. Delreno, I. De Santis, M.P. Salerno, A. Gargiulo, M. Castagneto
Predictive Role of the INDANA CV Score System in Kidney Transplant Recipients
2010 M.P. Salerno, E. Zichichi, E. Rossi, E. Favi, A. Gargiulo, G. Spagnoletti, M. Castagneto, F. Citterio
The Combination of Everolimus and Low Dose Cyclosporine Allows Similar Results as the Standard Tacrolimus and MMF Regimen: 3-Year Results of a Prospective Clinical Trial in Renal Transplant Recipients
2010 E. Favi, G. Spagnoletti, A. Gargiulo, J. Romagnoli, M. Castagneto, F. Citterio
Induction With Basiliximab Plus Thymoglobulin Is Effective and Safe in Old-for-Old Renal Transplantation: Six-Month Results of a Prospective Clinical Study
2010 E. Favi, A. Gargiulo, G. Spagnoletti, M.P. Salerno, N. Silvestrini, I. Valente, F. Citterio
Lower Acute Rejection with Basiliximab and Short Course, Low Dose Thymoglobulin vs Basiliximab as Induction Therapy in Deceased Donor Renal Transplant Recipients: 6-Month Results of a Prospective Clinical Trial
2010 E. Favi, N. Silvestrini, I. Valente, M. Salerno, M. Castagneto, F. Citterio
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile